Pharmadiet, the Spain subsidiary of OPKO Health, has obtained Spanish approval for commercialization of its oral and injectable formulations of citicoline, developed to enhance phosphatidylcholine levels in the brain. Agencia Espa ola de ...
The authorities in Italy have granted commercialization approval for GW Pharmaceuticals' Sativex prescription medication. Sativex is indicated for the treatment of moderate to severe spasticity in multiple sclerosis (MS) in patients who ...
Tags: GW Pharmaceutical, Medicine